Style | Citing Format |
---|---|
MLA | Eizadimood N, et al.. "Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study." Medical Journal Armed Forces India, vol. 81, no. 1, 2025, pp. 72-79. |
APA | Eizadimood N, Miranzade N, Haddad S, Aliabadi MG, Golshiri P, Meamar R (2025). Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study. Medical Journal Armed Forces India, 81(1), 72-79. |
Chicago | Eizadimood N, Miranzade N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. "Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study." Medical Journal Armed Forces India 81, no. 1 (2025): 72-79. |
Harvard | Eizadimood N et al. (2025) 'Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study', Medical Journal Armed Forces India, 81(1), pp. 72-79. |
Vancouver | Eizadimood N, Miranzade N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study. Medical Journal Armed Forces India. 2025;81(1):72-79. |
BibTex | @article{ author = {Eizadimood N and Miranzade N and Haddad S and Aliabadi MG and Golshiri P and Meamar R}, title = {Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study}, journal = {Medical Journal Armed Forces India}, volume = {81}, number = {1}, pages = {72-79}, year = {2025} } |
RIS | TY - JOUR AU - Eizadimood N AU - Miranzade N AU - Haddad S AU - Aliabadi MG AU - Golshiri P AU - Meamar R TI - Comparison of Clinicodemographic Characteristics in Patients With Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study JO - Medical Journal Armed Forces India VL - 81 IS - 1 SP - 72 EP - 79 PY - 2025 ER - |